Diagnostic and Biotech

2016 World Emerging Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • VPG338079
  • 1200 Pages
  • October 2015
  • Diagnostic and Biotech

Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100.

Highlights

- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next
five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
- Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual tumor marker
and country.

-
Five-year test volume and sales forecasts for major
tumor markers by country and market segment,
including:

- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

- Cancer statistics, etiology and recent developments in the
U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging tumor markers,
including:

- Biochemical Markers
- Oncogenes
- Growth Factors
- Hormones
- Colony Stimulating Factors
- Lymphokines
- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for
tumor marker testing, including their operating characteristics,
features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and their
potential applications for tumor marker testing.

- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and
research centers developing new tumor markers and detection technologies.

Competitive Assessments

- Extensive strategic assessments of major suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing tumor marker testing
by country.

- Ten-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors,
executives from leading diagnostic companies and start-up firms
developing innovative products, university scientists, as well as
experts from industry associations, venture capital firms and the
investment banking community in the U.S., five major European
countries and Japan.

The market projections are also based on questionnaire
responses received from hospitals, commercial/private laboratories,
physician offices/group practices, cancer clinics and ambulatory
care centers in seven countries.

In addition to primary sources of information, a comprehensive
review of the most recent technical and business publications, manufacturer
product literature, patents, trade association surveys, government
studies, marketing and technical meeting presentations,
industry analyst reports, and VPGMarketResearch's proprietary data files was conducted.

Contains 1,200 pages and 450 tables

<
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Allergy Diagnostic Market - Opportunities and Forecasts, 2014 - 2020

Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Respiratory Syncytial Virus (RSV) Diagnostic Market (Technology, End Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Respiratory syncytial virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapies and Diagnostics for Cervical Cancer Market, (Types, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Blood Plasma Derivatives Market (Type, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Blood plasma is the liquid component of blood constituting the extracellular matrix. Blood plasma plays a crucial role in maintaining the electrolyte and osmotic balance whilst preventing infection and blood ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>